VF
EDSA icon

Virtu Financial’s Edesa Biotech EDSA Stock Holding History

Virtu Financial’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,275
Closed -$137K – 1772
2026
Q1 		$137K Buy
+26,275
New +$78.8K 0.01% 1123
2022
Q1 		– Sell
-2,132
Closed -$84K – 1631
2021
Q4 		$84K Sell
2,132
-12,941
-86% -$619K 0.01% 1199
2021
Q3 		$779K Buy
15,073
+12,368
+457% +$481K 0.07% 293
2021
Q2 		$100K Buy
2,705
+400
+17% +$16.2K 0.01% 1205
2021
Q1 		$87K Buy
+2,305
New +$92.9K 0.01% 1351
2019
Q2 		– Sell
-380
Closed -$17K – 1548
2019
Q1 		$17K Buy
+380
New +$18.7K ﹤0.01% 1295
2018
Q4 		– Sell
-389
Closed -$23K – 1651
2018
Q3 		$23K Buy
+389
New +$24.8K ﹤0.01% 1396
2018
Q2 		– Sell
-36
Closed -$9K – 2086
2018
Q1 		$9K Buy
+36
New +$8.9K ﹤0.01% 1855

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial's EDSA Position: Q2 2026 in Review

Virtu Financial sold out of Edesa Biotech (EDSA) in Q2 2026, closing a stake of 26,275 shares — an estimated $137K sold.

Virtu Financial first reported a position in EDSA in Q1 2018 and held it in 8 quarters. The position peaked at $779K in Q3 2021. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Virtu Financial reported no remaining Edesa Biotech position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 26,275 Edesa Biotech shares in Q2 2026, an estimated $137K.
  • Virtu Financial first reported a position in Edesa Biotech in Q1 2018 and held it in 8 quarters.
  • Virtu Financial's Edesa Biotech position peaked at $779K in Q3 2021.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.